Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronika Lappe

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|February 11, 2017
[Anti-Diabetic Medication During the First Four Years of Treatment. A Study Based on Claims Data]Veronika Lappe, Ingrid Köster, Ingrid Schubert
Deutsche Medizinische Wochenschrift (1946)|January 6, 2017
[Anti-Diabetic Medication During the First Four Years of Treatment. A Study Based on Claims Data]Veronika Lappe, Ingrid Köster, Ingrid Schubert
European Journal of Clinical Pharmacology|September 19, 2023
Missing PPI prescriptions while overprescribing?Ingrid Schubert, Veronika Lappe, Ursula Marschall, et al.
Schmerz (Berlin, Germany)|December 5, 2024
[Opioid prescriptions for insured individuals without cancer in Germany: data from the BARMER]Veronika Lappe, Daniel Grandt, Ursula Marschall, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|April 12, 2019
[Cancer Patients and the Last Year of Life: Palliative Care, Hospitalization and Place of Death]Katja Blaschke, Kerstin Hermes-Moll, Veronika Lappe, et al.
Current Medical Research and Opinion|October 27, 2018
Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implicationsIva Selke Krulichová, Gisbert W Selke, Uwe Eichler, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 25, 2017
[Primary and secondary data on dementia care as an example of regional health planning]Lisa-R Ulrich, Tanja R Schatz, Veronika Lappe, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 11, 2018
[Erratum to: Prevalence of dementia of insured persons with and without German citizenship : A study based on statutory health insurance data]Stephanie Stock, Peter Ihle, Dusan Simic, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 1, 2018
[Prevalence of dementia of insured persons with and without German citizenship : A study based on statuatory health insurance data]Stephanie Stock, Peter Ihle, Dusan Simic, et al.
Scientific Reports|September 27, 2023
Gestational diabetes in Germany-prevalence, trend during the past decade and utilization of follow-up care: an observational studyVeronika Lappe, Gregory Gordon Greiner, Ute Linnenkamp, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|February 11, 2017
[Anti-Diabetic Medication During the First Four Years of Treatment. A Study Based on Claims Data]Veronika Lappe, Ingrid Köster, Ingrid Schubert
Deutsche Medizinische Wochenschrift (1946)|January 6, 2017
[Anti-Diabetic Medication During the First Four Years of Treatment. A Study Based on Claims Data]Veronika Lappe, Ingrid Köster, Ingrid Schubert
European Journal of Clinical Pharmacology|September 19, 2023
Missing PPI prescriptions while overprescribing?Ingrid Schubert, Veronika Lappe, Ursula Marschall, et al.
Schmerz (Berlin, Germany)|December 5, 2024
[Opioid prescriptions for insured individuals without cancer in Germany: data from the BARMER]Veronika Lappe, Daniel Grandt, Ursula Marschall, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|April 12, 2019
[Cancer Patients and the Last Year of Life: Palliative Care, Hospitalization and Place of Death]Katja Blaschke, Kerstin Hermes-Moll, Veronika Lappe, et al.
Current Medical Research and Opinion|October 27, 2018
Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implicationsIva Selke Krulichová, Gisbert W Selke, Uwe Eichler, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 25, 2017
[Primary and secondary data on dementia care as an example of regional health planning]Lisa-R Ulrich, Tanja R Schatz, Veronika Lappe, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 11, 2018
[Erratum to: Prevalence of dementia of insured persons with and without German citizenship : A study based on statutory health insurance data]Stephanie Stock, Peter Ihle, Dusan Simic, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 1, 2018
[Prevalence of dementia of insured persons with and without German citizenship : A study based on statuatory health insurance data]Stephanie Stock, Peter Ihle, Dusan Simic, et al.
Scientific Reports|September 27, 2023
Gestational diabetes in Germany-prevalence, trend during the past decade and utilization of follow-up care: an observational studyVeronika Lappe, Gregory Gordon Greiner, Ute Linnenkamp, et al.
Pageof 2